Resources
| Title | |||
|---|---|---|---|
|
PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT 1 0 download |
RESOURCE MATERIALS | 1 October 2024 | Download |
|
HUMAN RIGHTS GUIDELINES FOR PHARMACEUTICAL COMPANIES IN RELATION TO ACCESS TO MEDICINES: THE SEXUAL AND REPRODUCTIVE HEALTH CONTEXT 1 0 download |
RESOURCE MATERIALS | 1 October 2024 | Download |
|
A MODEL QUALITY ASSURANCE SYSTEM FOR PROCUREMENT AGENCIES 1 0 download |
RESOURCE MATERIALS | 1 October 2024 | Download |
|
PROMOTING SAFETY OF MEDICINES FOR CHILDREN 1 0 download |
RESOURCE MATERIALS | 30 September 2024 | Download |
|
OPERATIONAL PRINCIPLES FOR GOOD PHARMACEUTICAL PROCUREMENT 1 1 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
HOW TO DEVELOP A NATIONAL FORMULARY BASED ON THE WHO MODEL FORMULARY 1 0 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
HOW TO INVESTIGATE THE USE OF MEDICINES BY CONSUMERS 1 1 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
HOW TO INVESTIGATE DRUG USE IN HEALTH FACILITIES: SELECTED DRUG USE INDICATORS 1 0 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
HOW TO IMPROVE THE USE OF MEDICINES BY CUSTOMERS 1 0 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
HOW TO DEVELOP AND IMPLEMENT A NATIONAL DRUG POLICY 1 0 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
HANDBOOK OF SUPPLY MANAGEMENT AT FIRST-LEVEL HEALTH CARE FACILITIES: WORKING DOCUMENT FOR FIELD TESTING AND REVIEW 1 0 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
GUIDELINES FOR PRICE DISCOUNTS OF SINGLE-SOURCE PHARMACEUTICALS 1 0 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
WHO OPERATIONAL PACKAGE FOR ASSESSING, MONITORING, AND EVALUATING COUNTRY PHARMACEUTICAL SITUATIONS: GUIDE FOR COORDINATORS AND DATA COLLECTORS 1 1 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
GUIDE TO GOOD STORAGE PRACTICES FOR PHARMACEUTICALS 1 2 downloads |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
MEASURING TRANSPARENCY IN THE PUBLIC PHARMACEUTICAL SECTOR: ASSESSMENT INSTRUMENT 1 0 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
EFFECTIVE DRUG REGULATION: WHAT CAN COUNTRIES DO? 1 1 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
UNDERSTANDING AND RESPONDING TO PHARMACEUTICAL PROMOTION 1 0 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
GUIDELINES FOR DRUG DONATIONS 1 0 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
SAFETY OF MEDICINES: A GUIDE TO DETECTING AND REPORTING ADVERSE DRUG REACTIONS: WHY HEALTH PROFESSIONALS NEED TO TAKE ACTION 1 1 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
ACCESS TO AND USE OF MEDICINES BY HOUSEHOLDS IN UGANDA: REPORT OF A SURVEY CONDUCTED 2008 1 0 download |
RESOURCE MATERIALS | 27 September 2024 | Download |
|
HESITANCY IN COVID-19 VACCINE UPTAKE IN UGANDA 1 3 downloads |
RESOURCE MATERIALS | 19 February 2024 | Download |
